An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021184
Company: ALLERGAN

Products on NDA 021184

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
AVAGE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	AB	Yes	Yes
TAZORAC	TAZAROTENE	0.05%	CREAM;TOPICAL	Prescription	AB	Yes	Yes
TAZORAC	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021184

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/29/2000	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21184lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/21184ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/21-184_Tazorac.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/21/2017	SUPPL-9	Labeling-Package Insert	Label (PDF) Letter (PDF)	Label for Avage and Tazorac	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021184s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021184Orig1s009,020600Orig1s009ltr.pdf
09/16/2016	SUPPL-8	Labeling-Package Insert	Label (PDF) Letter (PDF)	Avage label updated	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021184s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021184Orig1s008ltr.pdf
12/13/2013	SUPPL-7	Labeling-Package Insert	Label (PDF) Letter (PDF)	Tazorac label updated	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021184s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021184Orig1s007ltr.pdf
09/30/2002	SUPPL-2	Efficacy-New Indication	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21184s2lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/21184se1-002ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-184s002_Avage.cfm
10/11/2001	SUPPL-1	Efficacy-New Indication	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21184s1lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/21184s1ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/21-184S001_Tazorac.cfm

Labels for NDA 021184

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
07/21/2017	SUPPL-9	Labeling-Package Insert	Label (PDF)	Label for Avage and Tazorac	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021184s009lbl.pdf
09/16/2016	SUPPL-8	Labeling-Package Insert	Label (PDF)	Avage label updated	https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021184s008lbl.pdf
12/13/2013	SUPPL-7	Labeling-Package Insert	Label (PDF)	Tazorac label updated	https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021184s007lbl.pdf
09/30/2002	SUPPL-2	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/21184s2lbl.pdf
10/11/2001	SUPPL-1	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21184s1lbl.pdf
09/29/2000	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21184lbl.pdf

Therapeutic Equivalents for NDA 021184

AVAGE

CREAM;TOPICAL; 0.1%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AVAGE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	Yes	AB	021184	ALLERGAN
TAZAROTENE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	No	AB	208662	COSETTE
TAZAROTENE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	No	AB	208258	TARO
TAZORAC	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	Yes	AB	021184	ALLERGAN

TAZORAC

CREAM;TOPICAL; 0.05%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
TAZAROTENE	TAZAROTENE	0.05%	CREAM;TOPICAL	Prescription	No	AB	208662	COSETTE
TAZAROTENE	TAZAROTENE	0.05%	CREAM;TOPICAL	Prescription	No	AB	217075	PADAGIS ISRAEL
TAZORAC	TAZAROTENE	0.05%	CREAM;TOPICAL	Prescription	Yes	AB	021184	ALLERGAN

CREAM;TOPICAL; 0.1%
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
AVAGE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	Yes	AB	021184	ALLERGAN
TAZAROTENE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	No	AB	208662	COSETTE
TAZAROTENE	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	No	AB	208258	TARO
TAZORAC	TAZAROTENE	0.1%	CREAM;TOPICAL	Prescription	Yes	AB	021184	ALLERGAN

Top